GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Endologix Inc (ELGX) [hlAlert]

Rating:
Perform ELGX
up 96.06 %

Endologix Inc (ELGX) rated Perform with price target $16 by Oppenheimer

Posted on: Friday,  Feb 28, 2014  8:25 AM ET by Oppenheimer

Oppenheimer rated Perform Endologix Inc (NASDAQ: ELGX) on 02/28/2014. Previously Oppenheimer rated Outperform Endologix Inc (NASDAQ: ELGX) on 12/15/2010.,
when the stock price was $6.61. Since then, Endologix Inc has gained 96.07% as of 01/14/2016's recent price of $12.96.
If you would have followed the previous Oppenheimer's recommendation on ELGX, you would have gained 96.06% of your investment in 1856 days.

Endologix, Inc., incorporated in March 1992, develops, manufactures, markets and sells treatments for aortic disorders. The Company?s product, the Powerlink System is a minimally invasive device for the treatment of abdominal aortic aneurysm (AAA). AAA is a weakening of the wall of the aorta, an artery of the body. Once AAA develops, it continues to enlarge and if left untreated becomes susceptible to rupture. The Powerlink System is a catheter and endoluminal stent graft (ELG) system. The device consists of a self-expanding cobalt chromium alloy stent cage covered by expanded polytetrafluoroethylene (ePTFE), a surgical graft material. Sale of its Powerlink System in the United States, Europe, Japan and Latin America are the primary sources of the Company?s revenues.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/28/2014 8:25 AM Buy
None
13.50 16.00
as of 10/17/2014
1 Week up  4.04 %
1 Month down  -19.43 %
3 Months down  -19.94 %
1 YTD down  -35.09 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/15/2010 8:25 AM Buy
None
6.61 10.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy